Mô tả

Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.

Figure 20

Diagram

Source Paper

Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel Disease.

Pharmaceuticals (Basel, Switzerland) (2023)

PMID: 37631065

DOI: 10.3390/ph16081150

Cite This Figure

![Figure 20: Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation." />
  <figcaption>Figure 20. Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>

Bằng chứng liên quan

Curcumin cho Ulcerative Colitis (UC)

Xếp hạng B · 5 nghiên cứu

N-Acetyl Cysteine (NAC) cho Inflammatory Bowel Disease (IBD) — General

Xếp hạng D · 1 nghiên cứu